Outcome MeasureDepression

CDRS-R

Children's Depression Rating Scale – Revised

2 Papers in Blossom

Outcome Data Across Studies

Reported results for CDRS-R across 2 studies with quantitative data.

Papers Using CDRS-R

Open Accessindividual

Single dose IV ketamine for adolescent suicidal ideation in the emergency department: a pilot randomized trial

This double-blind, randomised, placebo-controlled pilot trial (n=20) tested a single IV dose of ketamine for suicidal thoughts in adolescents attending the emergency department. It found the study was feasible and well tolerated, but ketamine did not clearly reduce suicidal ideation at 40 minutes, although fewer participants were admitted to hospital at the initial visit.

Published
Journal
BMC Psychiatry
Authors
Schlegelmilch, M., Plint, A. C., Barrowman, N., Gray, C., Crawford, T., Kutcher, S. A., Bhatt, M.
Open Accessindividual

Intravenous Ketamine for Adolescents with Treatment-Resistant Depression: An Open-Label Study

This open-label study (n=13) probed into the efficacy and tolerability of intravenous ketamine in adolescents with treatment-resistant depression (TRD), and investigated clinical response predictors using the Children's Depression Rating Scale-Revised (CDRS-R) and the Clinician-Administered Dissociative States Scale (CADSS). It supported the potential of ketamine in the treatment of adolescent patients with TRD and a dose-response relationship but called for larger sample size and overcoming limitations such as the open-label design and further research.

Published
Journal
Journal of Child and Adolescent Psychopharmacology
Authors
Cullen, K. R., Amatya, P., Roback, M. G., Albott, C. S., Schreiner, M. W., Ren, Y., Eberly, L. E., Carstedt, P., Samikoglu, A., Gunlicks-Stoessel, M., Reigstad, K., Horek, N., Tye, S., Lim, K. O., Klimes-Dougan, B.

Quick Facts

Full Name
Children's Depression Rating Scale – Revised
Domain
Depression
Papers Indexed
2
Score Range
17–113
Interpretation
Lower = better
Unit
points
All Measures